SCHEMBL13601633

SCHEMBL13601633

CC1CCN(C(=O)CCC(=O)OCCCN(C)C)CC1

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.55
ALDH1A1 P00352 7/20 0.48
HPGD P15428 4/20 0.48
LMNA P02545 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 3/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 2/20 0.41
DNM1 Q05193 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601630 0.92 NPC1 (0.54) NPC1ALDH1A1HPGDLMNAMEN1
SCHEMBL13601627 0.86 NPC1 (0.58) NPC1ALDH1A1HPGDLMNAMEN1
SCHEMBL12881501 0.85 GNAI3 (0.51) NPC1ALDH1A1HPGDLMNAMEN1
SCHEMBL13601667 0.84 TSHR (0.42) NPC1ALDH1A1HPGDLMNAMEN1
SCHEMBL13601418 0.83 POLB (0.46) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601628 0.83 NPC1 (0.55) NPC1ALDH1A1HPGDLMNAMEN1
SCHEMBL13601626 0.82 NPC1 (0.57) NPC1ALDH1A1HPGDLMNAMEN1
SCHEMBL12881521 0.82 BDKRB1 (0.42) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL12881529 0.81 BDKRB1 (0.41) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL19884745 0.81 NPC1 (0.46) NPC1ALDH1A1HPGDLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed